CLOTILDIA - CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients
Project objectivesThe aim of the CLOTILDIA study is to compare the efficacy of treatment with high-dose clopidogrel (150 mg/day) and treatment with ticagrelor (90 mg bid) on the degree of inhibition of platelet reactivity and in the prevention of medium-term ischemic events in patients with diabetes mellitus undergoing coronary angioplasty. |
Start and end date |
|
4 / 2012 - 1 / 2015 |
Project Manager |
|
Dr. Fabio Mangiacapra - Principal Investigator Prof. Germano Di Sciascio |
Coordinating institution of the project |
|
Università Campus Bio-Medico di Roma |
Other Institutions involved |
|
Cardiovascular Center, OLV Hospital, Aalst (Belgium) |
